Sex-Selective Abortion Ban Rejected By House
The House on Thursday voted down a bill that would have banned abortions based on the sex of a fetus. Republicans, however, said they achieved a strategic goal of forcing Democrats to vote against it.
The independent source for health policy research, polling, and news.
50,441 - 50,460 of 112,425 Results
The House on Thursday voted down a bill that would have banned abortions based on the sex of a fetus. Republicans, however, said they achieved a strategic goal of forcing Democrats to vote against it.
In political developments, a new poll shows a significant divide among Catholics but little support among general voters in New York for the church's complaints about the Obama administration rule. Also, in Minnesota, a new candidate opens his campaign for Congress and criticizes the state's handling of Medicaid funds.
A plan by New York City Mayor Michael Bloomberg to limit the sale of large sugary drinks is being met by apprehension by the food industry as other states' leaders consider what example the restrictions could provide for them.
Massachusetts officials had argued to the three-judge panel that the law could deny gay married couples federal benefits such as Medicaid.
This summer, United Healthcare will share $3.5 million in rebates with California small businesses as a part of a requirement of the health law - if it indeed is in effect.
A selection of health policy stories from Massachusetts, California, North Carolina, Illinois, Texas, Michigan, Kansas and Wisconsin.
The House Ways and Means Committee voted to eliminate a 2.3 percent tax on medical devices and to end a ban on the use of pretax flexible spending accounts to buy nonprescription medicines. These measures, though, are not expected to advance in the Senate even if they pass the full House.
A selection of editorials and opinions on health care policy from around the country.
News outlets report on how various players are braced for the ruling. Meanwhile, President Barack Obama tells donors he may have to revisit the law in a second term depending on what the court decides.
This week's studies come from the Archives of Internal Medicine, Journal of General Internal Medicine, Mathematica Policy Research, The Kaiser Family Foundation, The Urban Institute and other news outlets.
At a meeting this week, some state Medicaid directors expressed concern that their programs will not be able to handle the scheduled 2014 surge in enrollment because of challenges like outdated technology and the uncertainty of what will happen with the Supreme Court and November elections. Meanwhile, a committee of the National Association of Insurance Commissioners will offer recommendations on how to close a potential loophole in the law's employer coverage requirements.
Today's early morning highlights from the major news organizations, including reports about the latest health policy developments on Capitol Hill and news on the health insurance marketplace.
But the measure's supporters have not yet identified how they would make up for the lost revenue.
This projection is more than three times that of the expected rates for inflation and economic growth, according to PricewaterhouseCoopers. Still, it's the fourth year in which the cost increase is less than 8 percent.
"The World Health Organization (WHO) hopes to hold a meeting late this fall to discuss 'dual-use' research issues raised in the controversy over publication of two studies involving lab-modified H5N1 viruses with increased transmissibility, a WHO official said," CIDRAP News reports. "The WHO hosted a closed meeting of disease experts and government officials Feb 16 and 17 to discuss the two H5N1 studies," CIDRAP notes, adding that "the WHO [on Wednesday] released a brief statement about its activities related to the H5N1 research controversy since the February meeting in Geneva." Keiji Fukuda, the WHO's assistant director-general for health security and environment, said, "We hope to hold a second meeting to discuss the broader concerns related to potential dual [use] research in the late fall, if resources are available," the news service notes.
"In a newly released clinical study, conducted in India" and published in the Lancet on Thursday, "hundreds of seriously ill infants who received zinc -- an essential micronutrient for the immune system and human growth -- as well as antibiotics, responded better and more quickly to treatment than those who did not," IRIN reports, adding, "This finding is the first proof that zinc supplements may boost infant survival from infections." According to the news service, "More than 300 infants no older than 120 days (four months), hospitalized in New Delhi, the capital, for suspected meningitis (an infection of the brain or spinal cord lining), pneumonia (a lung infection) or sepsis (blood poisoning), were given zinc in addition to antibiotics" and "were found to be 40 percent less likely to experience 'treatment failure' -- needing a second antibiotic within one week of the first treatment, or intensive care or death within 21 days -- than those given a placebo."
Health law issues are reverberating as state officials consider what the law means for them -- especially if it stands after a Supreme Court review.
Officials report accords with public employees restricting pension increases in order to keep the programs solvent. Both deals also involve changes to retiree health care programs.
In other Medicaid news: In Oregon, Gov. John Kitzhaber has convinced the federal government that he has a way to make Medicaid treatment better, and Georgia faces risks as it moves all of its Medicaid patients to managed care.
The Massachusetts House has revised its health care cost containment bill, leaving several provisions intact -- including one directing the industry to cut spending growth in half by 2016.
© 2026 KFF